Wang Rui, Liang Ze-Yan, Chen Yan, Chen Chun-Mei
Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China.
Front Surg. 2023 Jan 5;9:1053885. doi: 10.3389/fsurg.2022.1053885. eCollection 2022.
The development of minimally invasive surgery has promoted the use of the paraspinal mini-tubular technique (PMTT) for spinal tumors. The similarity of the efficacy of PMTT to that of traditional surgery remains unclear; randomized controlled trials (RCTs) have not been conducted to investigate this technique for spinal tumors. The conventional surgery used for such tumors is laminoplasty (LP). To compare the differences between the two surgical techniques, an RCT is significantly required. Therefore, a prospective, multi-center, non-inferiority RCT was designed to compare the safety and effectiveness of LP and PMTT for treating spinal intradural extramedullary (IDEM) tumors. Moreover, the availability of PMTT, including its advantages and disadvantages, surgical indications, procedures, complications, and prognosis, would be explored. Overall, 280 patients will be randomly allocated to the PMTT and LP groups in a 1:1 ratio. The trial hypothesis is that PMTT has superior or equivalent efficacy and cost-effectiveness to LP. The primary outcome is the Japanese Orthopedic Association score. The non-inferiority margin for the primary outcome is five. The Ethics Committee of Fujian Medical University Union Hospital, Fuzhou, China, has approved this study (project number: FJMUUH05). Any results of the trial will be published in international peer-reviewed journals and disseminated through presentations at scientific conferences.
ChiCTR2100047582.
微创手术的发展推动了椎旁微管技术(PMTT)在脊柱肿瘤治疗中的应用。PMTT与传统手术疗效的相似性尚不清楚;尚未进行随机对照试验(RCT)来研究该技术用于脊柱肿瘤的情况。用于此类肿瘤的传统手术是椎板成形术(LP)。为比较这两种手术技术的差异,显著需要进行一项RCT。因此,设计了一项前瞻性、多中心、非劣效性RCT,以比较LP和PMTT治疗脊髓硬膜内髓外(IDEM)肿瘤的安全性和有效性。此外,还将探讨PMTT的可行性,包括其优缺点、手术适应症、手术步骤、并发症和预后。总体而言,280例患者将按1:1的比例随机分配至PMTT组和LP组。试验假设是PMTT的疗效和成本效益优于或等同于LP。主要结局指标是日本骨科协会评分。主要结局指标的非劣效界值为5。中国福州福建医科大学附属协和医院伦理委员会已批准本研究(项目编号:FJMUUH05)。试验的任何结果都将发表在国际同行评审期刊上,并通过在科学会议上的报告进行传播。
ChiCTR2100047582。